Projects
Strategic asset sharing
Combining proprietary resources to surpass what any individual organization can achieve.
In order to address growing complexity and successfully develop new solutions, stakeholders in biomedical research need each other – and each other’s proprietary resources.
An organization’s success depends on resources such as compounds, data, imaging/diagnostic technologies, or scientific expertise. However, making the most of these resources means having the vision to move beyond simply protecting them, and instead to start exploring their wider potential.
Working together with suitable partners at the early stages of technology development or drug discovery can yield results that surpass what any individual organization could achieve on its own. This is one of the most important ways in which organizations can take their own work and achievements to the next level.
Lygature helps to facilitate and safeguard the flow of competitive information between partners. Proven capabilities as an independent intermediary mean that resources can be effectively and safely shared, and more ambitious programs completed.
Portfolio
CONTRAST 2.0
A multi-stakeholder effort continued from CONTRAST to develop innovative stroke treatments and how logistics of treatment can be improved.
Goal: To improve the outcome for a large group of patients that suffered from cerebral infarction, cerebral vascular stoke or cerebral haemorrhage by also focusing on the phase before and after treatment.
> More
PREDICTOM
Public private partnership to bring dementia diagnostics closer to the public through a customisable cognitive and biomarker screening platform.
Goal: To establish scalable, cost-efficient diagnostic markers, tools and procedures that can identify people at increased risk, at point of care for stratification into personalized interventions to prevent or delay dementia.
> More
PERSIST-SEQ
International collaborative research project aiming to build a reproducible single-cell sequencing workflow to capture tumour drug persistence.
Goal: To improve the understanding of therapeutic resistance in cancer and possibly create effective strategies to improve cancer treatment and prevent drug resistance.
> More
Trials@Home
A consortium exploring the opportunities of moving clinical trials from the traditional clinic setting to the participant's immediate surroundings.
Goal: To develop and test remote decentralised methods to streamline data collection, participant recruitment and retention.
> More
European Lead Factory
A pan-European drug discovery project and flagship open innovation resource.
Goal: Screening of novel drug targets against a Joint European Compound Library.
> More
EPND
Accelerating the discovery of diagnostics and treatment for neurodegenerative diseases by removing barriers to data and sample sharing and fostering collaboration.
Goal: The European Platform for Neurodegenerative Diseases (EPND) will integrate existing European initiatives to build an infrastructure that facilitates access to biological samples and data in order to accelerate biomarker discovery and validation and potentially aid the development of therapeutics for neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.
> More
RADAR-CNS (completed)
Pan-European research on the potential of wearable devices.
Goal: Helping to prevent and treat depression, multiple sclerosis and epilepsy.
> More
CONTRAST (completed)
A collaboration of academic researchers, private and public partners seeking to improve the treatment of acute stroke.
Goal: To develop innovative stroke treatments that improve patient outcomes and decrease the burden for those who survive a stroke.
> More